Costaining for HA and MBP showed a uniform distribution of HA and myelinating oligodendrocytes in the control sample, and an apparent concomitant degradation of HA and demyelination in the pons of the MS patient sample (Figure 9A–I). Here, MBP is linked to myeloid sarcoma.